David T. Melnekoff
- Molecular Biology
- Hematology top 10%
- Oncology
- Structural Biology top 2%
- Immunology
- Co-authors
- Alessandro LaganàSamir ParekhSundar JagannathVioletta V. LeshchenkoJoel T. DudleyAjai ChariZhening ZhangIvan Razinkov
- Topics
- Multiple Myeloma Research and Treatments (19 papers)Protein Degradation and Inhibitors (9 papers)CAR-T cell therapy research (4 papers)
- Partner nations
- United StatesIndia
In The Last Decade
David T. Melnekoff
22 papers receiving 347 citations
Peers
Comparison fields: 5 of 75
- Molecular Biology 205
- Hematology 118
- Oncology 81
- Structural Biology 75
- Immunology 60
Countries citing papers authored by David T. Melnekoff
This map shows the geographic impact of David T. Melnekoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David T. Melnekoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David T. Melnekoff more than expected).
Fields of papers citing papers by David T. Melnekoff
This network shows the impact of papers produced by David T. Melnekoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David T. Melnekoff. The network helps show where David T. Melnekoff may publish in the future.
Co-authorship network of co-authors of David T. Melnekoff
This figure shows the co-authorship network connecting the top 25 collaborators of David T. Melnekoff. A scholar is included among the top collaborators of David T. Melnekoff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David T. Melnekoff. David T. Melnekoff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 14 | |
| 3 | 15 | |
| 4 | 4 | |
| 5 | 7 | |
| 6 | 2 | |
| 7 | 7 | |
| 8 | 2 | |
| 9 | 56 | |
| 10 | 1 | |
| 11 | 59 | |
| 12 | 3 | |
| 13 | 3 | |
| 14 | 8 | |
| 15 | 22 | |
| 16 | 2 | |
| 17 | 2 | |
| 18 | 43 | |
| 19 | 95 | |
| 20 | 1 |
About David T. Melnekoff
David T. Melnekoff is a scholar working on Hematology, Structural Biology and Genetics, having authored 22 papers that have together received 350 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (19 papers), Protein Degradation and Inhibitors (9 papers) and CAR-T cell therapy research (4 papers). The work is most often cited by research in Structural Biology (75 citations), Hematology (118 citations) and Surfaces, Coatings and Films (35 citations). David T. Melnekoff has collaborated with scholars based in United States and India. Frequent co-authors include Alessandro Laganà, Samir Parekh, Sundar Jagannath, Violetta V. Leshchenko, Joel T. Dudley, Ajai Chari, Zhening Zhang, Ivan Razinkov, Hui Wei and William J. Rice. Their work appears in journals such as Blood, Clinical Cancer Research and Science Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.